Different individuals may understand or respond to the same information in diverse ways, depending on their unique thresholds for risk tolerance, burden or harm acceptance (for themselves or for their families), and their prioritization of benefits, as exemplified in the case of PSA (Prostate Specific Antigen) screening for prostate cancer detection [3–5]. This evidence concerns the gene KLK3 and prostate carcinoma.